Project Grant HT94252410558
Award Date
7/15/24
Completion Date
7/14/28
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
The University of Alabama at Birmingham (UAB) was awarded a $733,662 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2024, supports research to investigate the role of tumor glycans in immune suppression. This federally funded project aims to advance scientific understanding of how specific carbohydrate molecules on tumor cells can inhibit the body's immune response, with the goal of...
This federal Project Grant award, valued at $650,845.00 and provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports macrophage-centric prognostic biomarker research for checkpoint blockade immunotherapy in melanoma. The award, effective July 1, 2025, will fund advanced biomedical research initiatives at the University of Alabama at Birmingham (UAB) aimed at transforming healthcare for military service members and the broader...
This $1,485,001.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research at the University of Alabama at Birmingham (UAB) to investigate innovative approaches to overcoming immune exhaustion and dysfunction in breast cancer. The research aims to transform healthcare for military service members and the broader public by advancing scientific understanding and developing new treatment...
This Project Grant award of $1,113,750.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), supports the University of Alabama at Birmingham (UAB) in developing "DUAL CD24/CD276 TARGETING THERAPIES FOR TRIPLE-NEGATIVE BREAST CANCER." The 3-year award, running from August 1, 2023 to July 31, 2026, will fund research to investigate medical solutions for the battlefield and transform health care for service members and the public...
This $1,317,584 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research by the University of Alabama at Birmingham (UAB) focused on developing prognostic biomarkers for checkpoint blockade immunotherapy in melanoma. The funding will enable UAB to conduct research spanning basic, applied, and translational investigations to transform healthcare for military service...
This $227,167 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program supports research conducted by the University of Alabama at Birmingham (UAB) on macrophage-centric prognostic biomarkers for checkpoint blockade immunotherapy in melanoma. The award runs from July 1, 2025 through June 30, 2028 and aims to advance scientific understanding and treatment of this form of cancer. As a leading academic medical center, UAB has...
The University of Alabama at Birmingham (UAB) received a $1,599,981.00 Project Grant award from the Defense Health Agency on June 1, 2024 under the Military Medical Research and Development program (CFDA 12.420). The grant supports research to activate immune reserves and prevent secondary bacterial lung infections after trauma and hemorrhage. This biomedical research project aims to improve health outcomes for military service members and the broader public. The project will be conducted over a...
The federal Project Grant award of $525,799 from the Department of the Army Medical Command's Military Medical Research and Development (CFDA 12.420) program supports research by the University of Alabama to investigate targeting GPNMB to improve the efficacy of CDK4/6 inhibitors in ER+ breast cancer. The research aims to transform healthcare for military service members and the general public through innovative and impactful medical research. The project will be conducted over a 3-year period...
The University of Alabama at Birmingham (UAB) was awarded a $1,485,000.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to improve the oncolytic immunovirotherapy of malignant glioma by targeting the glioma secretome. The 3-year grant was awarded on September 30, 2023 and is set to conclude on September 29, 2026. UAB is a public research university known for its innovative and interdisciplinary approach to education, and it...
The University of Alabama at Birmingham (UAB) was awarded a $2,069,849 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The award will support UAB's research from May 1, 2023 to April 30, 2027 to understand cardiovascular disease in mental health and stress disorders. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research,...